Hormone replacement therapy for the critically ill *
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (2) , 634-635
- https://doi.org/10.1097/01.ccm.0000045569.14948.f2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*Critical Care Medicine, 2003
- Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes MellitusJAMA, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.Diabetes Care, 1999
- Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophyNature, 1999
- Insulin Infusion Improves Neutrophil Function in Diabetic Cardiac Surgery PatientsAnesthesia & Analgesia, 1999
- Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patientsCritical Care Medicine, 1998
- Energy Metabolism in Sepsis and InjuryNutrition, 1997
- Expression and function of P-glycoprotein in a mouse kidney cell lineAmerican Journal of Physiology-Cell Physiology, 1995